Table of Content

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Global Animal Drug Compounding Market Analysis and Forecast, by Product
3.1. Introduction & Definition
3.2. Key Findings / Developments
3.3. Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Product, 2018–2030
3.3.1. Anti-infectives
3.3.1.1. Metronidazole
3.3.1.2. Ketoconazole
3.3.1.3. Other Antibiotics
3.3.2. Anti-inflammatory
3.3.2.1. Prednisolone
3.3.2.2. Tramadol
3.3.2.3. Other Anti inflammatory
3.3.3. CNS Agents
3.3.3.1. Potassium bromide
3.3.3.2. Gabapentin
3.3.3.3. Other CNS agents
3.3.4. GI Drugs
3.3.4.1. Apomorphine
3.3.4.2. Ursodiol
3.3.4.3. Cisapride
3.3.4.4. Other GI Drugs
3.3.5. Others
3.3.5.1. Methimazole
3.3.5.2. Other drugs
3.4. Market Attractiveness Analysis, by Product

4. Global Animal Drug Compounding Market Analysis and Forecast, by Animal Type
4.1. Introduction & Definition
4.2. Key Findings / Developments
4.3. Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030
4.3.1. Companion Animal
4.3.1.1. Dogs
4.3.1.2. Cats
4.3.1.3. Others
4.3.2. Livestock
4.4. Global Animal Drug Compounding Market Attractiveness Analysis, by Animal Type

5. Global Animal Drug Compounding Market Analysis and Forecast, by Dosage Form
5.1. Introduction & Definition
5.2. Key Findings / Developments
5.3. Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
5.3.1. Capsule
5.3.2. Solution
5.3.3. Powders
5.3.4. Suspension
5.3.5. Others
5.4. Global Animal Drug Compounding Market Attractiveness Analysis, by Dosage Form

6. Global Animal Drug Compounding Market Analysis and Forecast, by Route of Administration
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030
6.3.1. Oral
6.3.2. Injectable
6.3.3. Topical
6.3.4. Rectal
6.3.5. Ocular
6.4. Global Animal Drug Compounding Market Attractiveness Analysis, by Route of Administration

7. Global Animal Drug Compounding Market Analysis and Forecast, by Region
7.1. Key Findings
7.2. Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Region
7.2.1. North America
7.2.2. Europe
7.2.3. Asia Pacific
7.2.4. Latin America
7.2.5. Middle East & Africa
7.3. Global Animal Drug Compounding Market Attractiveness Analysis, by Region

8. North America Animal Drug Compounding Market Analysis and Forecast
8.1. Introduction
8.1.1. Key Findings
8.2. North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Product, 2018–2030
8.2.1. Anti-infectives
8.2.1.1. Metronidazole
8.2.1.2. Ketoconazole
8.2.1.3. Other Antibiotics
8.2.2. Anti-inflammatory
8.2.2.1. Prednisolone
8.2.2.2. Tramadol
8.2.2.3. Other Anti inflammatory
8.2.3. CNS Agents
8.2.3.1. Potassium Bromide
8.2.3.2. Gabapentin
8.2.3.3. Other CNS agents
8.2.4. GI Drugs
8.2.4.1. Apomorphine
8.2.4.2. Ursodiol
8.2.4.3. Cisapride
8.2.4.4. Other GI Drugs
8.2.5. Others
8.2.5.1. Methimazole
8.2.5.2. Other drugs
8.3. North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030
8.3.1. Companion Animal
8.3.1.1. Dogs
8.3.1.2. Cats
8.3.1.3. Others
8.3.2. Livestock Animal
8.4. North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
8.4.1. Capsule
8.4.2. Solution
8.4.3. Powders
8.4.4. Suspension
8.4.5. Others
8.5. North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030
8.5.1. Oral
8.5.2. Injectable
8.5.3. Topical
8.5.4. Rectal
8.5.5. Ocular
8.6. North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
8.6.1. U.S.
8.6.2. Canada

9. Europe Animal Drug Compounding Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Product, 2018–2030
9.2.1. Anti-infectives
9.2.1.1. Metronidazole
9.2.1.2. Ketoconazole
9.2.1.3. Other Antibiotics
9.2.2. Anti-inflammatory
9.2.2.1. Prednisolone
9.2.2.2. Tramadol
9.2.2.3. Other Anti inflammatory
9.2.3. CNS Agents
9.2.3.1. Potassium Bromide
9.2.3.2. Gabapentin
9.2.3.3. Other CNS agents
9.2.4. GI Drugs
9.2.4.1. Apomorphine
9.2.4.2. Ursodiol
9.2.4.3. Cisapride
9.2.4.4. Other GI Drugs
9.2.5. Others
9.2.5.1. Methimazole
9.2.5.2. Other drugs
9.3. Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030
9.3.1. Companion Animal
9.3.1.1. Dogs
9.3.1.2. Cats
9.3.1.3. Others
9.3.2. Livestock Animal
9.4. Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
9.4.1. Capsule
9.4.2. Solution
9.4.3. Powders
9.4.4. Suspension
9.4.5. Others
9.5. Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030
9.5.1. Oral
9.5.2. Injectable
9.5.3. Topical
9.5.4. Rectal
9.5.5. Ocular
9.6. Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
9.6.1. Germany
9.6.2. U.K.
9.6.3. France
9.6.4. Italy
9.6.5. Spain
9.6.6. Rest of Europe
10. Asia Pacific Animal Drug Compounding Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Product, 2018–2030
10.2.1. Anti-infectives
10.2.1.1. Metronidazole
10.2.1.2. Ketoconazole
10.2.1.3. Other Antibiotics
10.2.2. Anti-inflammatory
10.2.2.1. Prednisolone
10.2.2.2. Tramadol
10.2.2.3. Other Anti inflammatory
10.2.3. CNS Agents
10.2.3.1. Potassium Bromide
10.2.3.2. Gabapentin
10.2.3.3. Other CNS agents
10.2.4. GI Drugs
10.2.4.1. Apomorphine
10.2.4.2. Ursodiol
10.2.4.3. Cisapride
10.2.4.4. Other GI Drugs
10.2.5. Others
10.2.5.1. Methimazole
10.2.5.2. Other drugs
10.3. Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030
10.3.1. Companion Animal
10.3.1.1. Dogs
10.3.1.2. Cats
10.3.1.3. Others
10.3.2. Livestock Animal
10.4. Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
10.4.1. Capsule
10.4.2. Solution
10.4.3. Powders
10.4.4. Suspension
10.4.5. Others
10.5. Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030
10.5.1. Oral
10.5.2. Injectable
10.5.3. Topical
10.5.4. Rectal
10.5.5. Ocular
10.6. Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
10.6.1. China
10.6.2. Japan
10.6.3. India
10.6.4. Australia & New Zealand
10.6.5. Rest of Asia Pacific

11. Latin America Animal Drug Compounding Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Introduction
11.2.1. Key Findings
11.3. Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Product, 2018–2030
11.3.1. Anti-infectives
11.3.1.1. Metronidazole
11.3.1.2. Ketoconazole
11.3.1.3. Other Antibiotics
11.3.2. Anti-inflammatory
11.3.2.1. Prednisolone
11.3.2.2. Tramadol
11.3.2.3. Other Anti inflammatory
11.3.3. CNS Agents
11.3.3.1. Potassium Bromide
11.3.3.2. Gabapentin
11.3.3.3. Other CNS agents
11.3.4. GI Drugs
11.3.4.1. Apomorphine
11.3.4.2. Ursodiol
11.3.4.3. Cisapride
11.3.4.4. Other GI Drugs
11.3.5. Others
11.3.5.1. Methimazole
11.3.5.2. Other drugs
11.4. Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030
11.4.1. Companion Animal
11.4.1.1. Dogs
11.4.1.2. Cats
11.4.1.3. Others
11.4.2. Livestock Animal
11.5. Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
11.5.1. Capsule
11.5.2. Solution
11.5.3. Powders
11.5.4. Suspension
11.5.5. Others
11.6. Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030
11.6.1. Oral
11.6.2. Injectable
11.6.3. Topical
11.6.4. Rectal
11.6.5. Ocular
11.7. Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
11.7.1. Brazil
11.7.2. Mexico
11.7.3. Rest of Latin America

12. Middle East & Africa Animal Drug Compounding Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Introduction
12.2.1. Key Findings
12.3. Introduction
12.3.1. Key Findings
12.4. Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Product, 2018–2030
12.4.1. Anti-infectives
12.4.1.1. Metronidazole
12.4.1.2. Ketoconazole
12.4.1.3. Other Antibiotics
12.4.2. Anti-inflammatory
12.4.2.1. Prednisolone
12.4.2.2. Tramadol
12.4.2.3. Other Anti inflammatory
12.4.3. CNS Agents
12.4.3.1. Potassium Bromide
12.4.3.2. Gabapentin
12.4.3.3. Other CNS agents
12.4.4. GI Drugs
12.4.4.1. Apomorphine
12.4.4.2. Ursodiol
12.4.4.3. Cisapride
12.4.4.4. Other GI Drugs
12.4.5. Others
12.4.5.1. Methimazole
12.4.5.2. Other drugs
12.5. Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030
12.5.1. Companion Animal
12.5.1.1. Dogs
12.5.1.2. Cats
12.5.1.3. Others
12.5.2. Livestock Animal
12.6. Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
12.6.1. Capsule
12.6.2. Solution
12.6.3. Powders
12.6.4. Suspension
12.6.5. Others
12.7. Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030
12.7.1. Oral
12.7.2. Injectable
12.7.3. Topical
12.7.4. Rectal
12.7.5. Ocular
12.8. Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
12.8.1. GCC Countries
12.8.2. South Africa
12.8.3. Rest of Middle East & Africa

13. Competitive Landscape
13.1. Market Player - Competition Matrix (by tier and size of companies)
13.2. Company Profiles
13.2.1. Wedgewood Pharmacy
13.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.1.2. Product Portfolio
13.2.1.3. Strategic Overview
13.2.1.4. SWOT Analysis
13.2.2. Triangle Compounding Pharmacy
13.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.2.2. Product Portfolio
13.2.2.3. Strategic Overview
13.2.2.4. SWOT Analysis
13.2.3. Davis Islands Pharmacy
13.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.3.2. Product Portfolio
13.2.3.3. Strategic Overview
13.2.3.4. SWOT Analysis
13.2.4. Custom Med Compounding Pharmacy
13.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.4.2. Product Portfolio
13.2.4.3. Strategic Overview
13.2.4.4. SWOT Analysis
13.2.5. Central Compounding Center South
13.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.5.2. Product Portfolio
13.2.5.3. Strategic Overview
13.2.5.4. SWOT Analysis
13.2.6. Wellness Pharmacy of Cary
13.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.6.2. Product Portfolio
13.2.6.3. Strategic Overview
13.2.6.4. SWOT Analysis
13.2.7. Caringbah Compounding Pharmacy
13.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.7.2. Product Portfolio
13.2.7.3. Strategic Overview
13.2.7.4. SWOT Analysis
13.2.8. Millers Pharmacy
13.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.8.2. Product Portfolio
13.2.8.3. Strategic Overview
13.2.8.4. SWOT Analysis
13.2.9. Smith’s Pharmacy
13.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.9.2. Product Portfolio
13.2.9.3. Strategic Overview
13.2.9.4. SWOT Analysis
13.2.10. Specialist Compounding Pharmacy Pte Ltd.
13.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.10.2. Product Portfolio
13.2.10.3. Strategic Overview
13.2.10.4. SWOT Analysis
13.2.11. Tache Pharmacy
13.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.11.2. Product Portfolio
13.2.11.3. Strategic Overview
13.2.11.4. SWOT Analysis



List of Figures



Figure 01: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, 2018–2030

Figure 02: Global Animal Drug Compounding Market Value Share, by Product, 2019

Figure 03: Global Animal Drug Compounding Market Value Share, by Route of Administration, 2019

Figure 04: Global Animal Drug Compounding Market Value Share, by Animal Type, 2019

Figure 05: Global Animal Drug Compounding Market Value Share Analysis, by Product, 2019 and 2030

Figure 06: Global Animal Drug Compounding Market Revenue (US$ Mn), by Anti-infectives, 2018–2030

Figure 07: Global Animal Drug Compounding Market Revenue (US$ Mn), by Anti-inflammatory, 2018–2030

Figure 08: Global Animal Drug Compounding Market Revenue (US$ Mn), by CNS Agents, 2018–2030

Figure 09 Global Animal Drug Compounding Market Revenue (US$ Mn), by GI Drugs, 2018–2030

Figure 10: Global Animal Drug Compounding Market Revenue (US$ Mn), by Others, 2018–2030

Figure 11: Global Animal Drug Compounding Market Attractiveness Analysis, by Product, 2020–2030

Figure 12: Global Animal Drug Compounding Market Value Share Analysis, by Animal Type, 2019 and 2030

Figure 13: Global Animal Drug Compounding Market Revenue (US$ Mn), by Companion Animal, 2018–2030

Figure 14: Global Animal Drug Compounding Market Revenue (US$ Mn), by Live Stock, 2018–2030

Figure 15: Global Animal Drug Compounding Market Attractiveness Analysis, by Animal Type, 2020–2030

Figure 16: Global Animal Drug Compounding Market Value Share Analysis, by Dosage Form, 2019 and 2030

Figure 17: Global Animal Drug Compounding Market Revenue (US$ Mn), by Capsule, 2018–2030

Figure 18: Global Animal Drug Compounding Market Revenue (US$ Mn), by Solution, 2018–2030

Figure 19: Global Animal Drug Compounding Market Revenue (US$ Mn), by Powders, 2018–2030

Figure 20: Global Animal Drug Compounding Market Revenue (US$ Mn), by Suspension, 2018–2030

Figure 21: Global Animal Drug Compounding Market Revenue (US$ Mn), by Others, 2018–2030

Figure 22: Global Animal Drug Compounding Market Attractiveness Analysis, by Dosage Form, 2020–2030

Figure 23: Global Animal Drug Compounding Market Value Share Analysis, by Route of Administration, 2019 and 2030

Figure 24: Global Animal Drug Compounding Market Revenue (US$ Mn), by Oral, 2018–2030

Figure 25: Global Animal Drug Compounding Market Revenue (US$ Mn), by Injectable, 2018–2030

Figure 26: Global Animal Drug Compounding Market Revenue (US$ Mn), by Topical, 2018–2030

Figure 27: Global Animal Drug Compounding Market Revenue (US$ Mn), by Rectal, 2018–2030

Figure 28: Global Animal Drug Compounding Market Revenue (US$ Mn), by Ocular, 2018–2030

Figure 29: Global Animal Drug Compounding Market Attractiveness Analysis, by Route of Administration, 2020–2030

Figure 30: Global Animal Drug Compounding Market Value Share Analysis, by Region, 2019 and 2030

Figure 31: Global Animal Drug Compounding Market Attractiveness Analysis, by Region, 2020–2030

Figure 32: North America Animal Drug Compounding Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 33: North America Animal Drug Compounding Market Value Share (%), by Country, 2019 and 2030

Figure 34: North America Animal Drug Compounding Market Attractiveness Analysis, by Country, 2020–2030

Figure 35: North America Animal Drug Compounding Market Value Share (%), by Product, 2019 and 2030

Figure 36: North America Animal Drug Compounding Market Attractiveness Analysis, by Product, 2020–2030

Figure 37: North America Animal Drug Compounding Market Value Share (%), by Animal Type, 2019 and 2030

Figure 38: North America Animal Drug Compounding Market Attractiveness Analysis, by Animal Type, 2020–2030

Figure 39: North America Animal Drug Compounding Market Value Share (%), by Dosage form, 2019 and 2030

Figure 40: North America Animal Drug Compounding Market Attractiveness Analysis, by Dosage form, 2020–2030

Figure 41: North America Animal Drug Compounding Market Value Share (%), by Route of Administration, 2019 and 2030

Figure 42: North America Animal Drug Compounding Market Attractiveness Analysis, by Route of Administration, 2020–2030

Figure 43: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 44: Europe Animal Drug Compounding Market Value Share (%), by Country/Sub-region, 2019 and 2030

Figure 45: Europe Animal Drug Compounding Market Attractiveness Analysis, by Country, 2020–2030

Figure 46: Europe Animal Drug Compounding Market Value Share (%), by Product, 2019 and 2030

Figure 47: Europe Animal Drug Compounding Market Attractiveness Analysis, by Product, 2020–2030

Figure 48: Europe Animal Drug Compounding Market Value Share (%), by Animal Type, 2019 and 2030

Figure 49: Europe Animal Drug Compounding Market Attractiveness Analysis, by Animal Type, 2020–2030

Figure 50: Europe Animal Drug Compounding Market Value Share (%), by Dosage Form, 2019 and 2030

Figure 51: Europe Animal Drug Compounding Market Attractiveness Analysis, by Dosage Form, 2020–2030

Figure 52: Europe Animal Drug Compounding Market Value Share (%), by Route of Administration, 2019 and 2030

Figure 53: Europe Animal Drug Compounding Market Attractiveness Analysis, by Route of Administration, 2020–2030

Figure 54: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 55: Asia Pacific Animal Drug Compounding Market Value Share (%), by Country/Sub-region, 2019 and 2030

Figure 56: Asia Pacific Animal Drug Compounding Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 57: Asia Pacific Animal Drug Compounding Market Value Share (%), by Product, 2019 and 2030

Figure 58: Asia Pacific Animal Drug Compounding Market Attractiveness Analysis, by Product, 2020–2030

Figure 59: Asia Pacific Animal Drug Compounding Market Value Share (%), by Animal Type, 2019 and 2030

Figure 60: Asia Pacific Animal Drug Compounding Market Attractiveness Analysis, by Animal Type, 2020–2030

Figure 61: Asia Pacific Animal Drug Compounding Market Value Share (%), by Dosage Form, 2019 and 2030

Figure 62: Asia Pacific Animal Drug Compounding Market Attractiveness Analysis, by Dosage Form, 2020–2030

Figure 63: Asia Pacific Animal Drug Compounding Market Value Share (%), by Route of Administration, 2019 and 2030

Figure 64: Asia Pacific Animal Drug Compounding Market Attractiveness Analysis, by Route of Administration, 2020–2030

Figure 65: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 66: Latin America Animal Drug Compounding Market Value Share (%), by Country/Sub-region, 2019 and 2030

Figure 67: Latin America Animal Drug Compounding Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 68: Latin America Animal Drug Compounding Market Value Share (%), by Product, 2019 and 2030

Figure 69: Latin America Animal Drug Compounding Market Attractiveness Analysis, by Product, 2020–2030

Figure 70: Latin America Animal Drug Compounding Market Value Share (%), by Animal Type, 2019 and 2030

Figure 71: Latin America Animal Drug Compounding Market Attractiveness Analysis, by Animal Type, 2020–2030

Figure 72: Latin America Animal Drug Compounding Market Value Share (%), by Dosage form, 2019 and 2030

Figure 73: Latin America Animal Drug Compounding Market Attractiveness Analysis, by Dosage form, 2020–2030

Figure 74: Latin America Animal Drug Compounding Market Value Share (%), by Route of Administration, 2019 and 2030

Figure 75: Latin America Animal Drug Compounding Market Attractiveness Analysis, by Route of Administration, 2020–2030

Figure 76: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 77: Middle East & Africa Animal Drug Compounding Market Value Share (%), by Country/Sub-region, 2019 and 2030

Figure 78: Middle East & Africa Animal Drug Compounding Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 79: Middle East & Africa Animal Drug Compounding Market Value Share (%), by Product, 2019 and 2030

Figure 80: Middle East & Africa Animal Drug Compounding Market Attractiveness Analysis, by Product, 2020–2030

Figure 81: Middle East & Africa Animal Drug Compounding Market Value Share (%), by Animal Type, 2019 and 2030

Figure 82: Middle East & Africa Animal Drug Compounding Market Attractiveness Analysis, by Animal Type, 2020–2030

Figure 83: Middle East & Africa Animal Drug Compounding Market Value Share (%), by Dosage Form, 2019 and 2030

Figure 84: Middle East & Africa Animal Drug Compounding Market Attractiveness Analysis, by Dosage Form, 2020–2030

Figure 85: Middle East & Africa Animal Drug Compounding Market Value Share (%), by Route of Administration, 2019 and 2030

Figure 86: Middle East & Africa Animal Drug Compounding Market Attractiveness Analysis, by Route of Administration, 2020–2030

Figure 87: Global Animal Drug Compounding Market Strategy, by Top Pharmacies, 2019


List of Tables



Table 01: Global & Asia Pacific Platelet Rich Plasma Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030

Table 02: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 03: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-infectives, 2018–2030

Table 04: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030

Table 05: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by CNS Agents, 2018–2030

Table 06: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by GI Drugs, 2018–2030

Table 07: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Others, 2018–2030

Table 08: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030

Table 09: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030

Table 10: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030

Table 11: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 12: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Region, 2018–2030

Table 13: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Country, 2018–2030

Table 14: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 15: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-infectives, 2018–2030

Table 16: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030

Table 17: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by CNS Agents, 2018–2030

Table 18: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by GI Drugs, 2018–2030

Table 19: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Others, 2018–2030

Table 20: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030

Table 21: North America Animal Drug Compounding Market Size (US$ Mn) Forecast, by Companion Animal Type, 2018–2030

Table 22: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Dosage form, 2018–2030

Table 23: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 24: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 25: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 26: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-infectives, 2018–2030

Table 27: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030

Table 28: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by CNS Agents, 2018–2030

Table 29: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by GI Drugs, 2018–2030

Table 30: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Others, 2018–2030

Table 31: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030

Table 32: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Companion Animal Types, 2018–2030

Table 33: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030

Table 34: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 35: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 36: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 37: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-infectives, 2018–2030

Table 38: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030

Table 39: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by CNS Agents, 2018–2030

Table 40: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by GI Drugs, 2018–2030

Table 41: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Others, 2018–2030

Table 42: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030

Table 43: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Companion Animal Type, 2018–2030

Table 44: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030

Table 45: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 46: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 47: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 48: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-infectives, 2018–2030

Table 49: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030

Table 50: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by CNS Agents, 2018–2030

Table 51: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by GI Drugs, 2018–2030

Table 52: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Others, 2018–2030

Table 53: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030

Table 54: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Companion Animal Type, 2018–2030

Table 55: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Dosage form, 2018–2030

Table 56: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 57: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 58: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 59: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-infectives, 2018–2030

Table 60: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030

Table 61: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by CNS Agents, 2018–2030

Table 62: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by GI Drugs, 2018–2030

Table 63: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by Others, 2018–2030

Table 64: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030

Table 65: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by Companion Animal Type, 2018–2030

Table 66: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030

Table 67: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030